Nevirapin Viatris 400 mg, Retardtabletten
7680667650027
CH-66765
Tabletten
Associated product:
NEVIRAPIN Viatris cpr ret 400 mg 30 pce
Fiches Amavita / Sun Store / Coop Vitality
Article details
- Package size
- 30
- Selling units
- 30
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
nevirapinum
|
400.0 MG | Substance | Wirkstoff (Principe actif) |
|
lactosum monohydricum
|
398.0 MG | Substance | HBESI |
|
hypromellosum
|
- | Substance | HNIDK |
|
natrii stearylis fumaras
|
- | Substance | HNIDK |
|
natrium
|
710.0 UG | Substance | HBESI |
Reimbursement information
Public price
CHF 193.35
Specialties list
Yes
Generic
Yes
SL addition date:
01/12/2018
Authorization holder
Viatris Pharma GmbH
6312 Steinhausen
Authorization information
- Swissmedic authorization number
- 66765
- Drug name
- Nevirapin Viatris, Retardtabletten
- Galenic form
- RETT
- ATC Code
- J05AG01
- Authorization status
- Z
- Dispensing category
- A
- First authorization
- 12/09/2018
- Authorization expiration date
- 31/12/9999
- IT Number
- 08.03.0.
- Domain
- Human medicine
Package details
- Description (FR)
- NEVIRAPIN Viatris cpr ret 400 mg 30 pce
- Description (DE)
- NEVIRAPIN Viatris Ret Tabl 400 mg 30 Stk
- Market launch
- 12/09/2018
- Narcotic (BTM)
- No
Other package sizes (1)
NEVIRAPIN Mylan cpr ret 400 mg 30 pce
None None
GTIN: 7680667650010